Comparing Composite Measures of Disease Activity in Psoriatic Arthritis: Results From a Randomized Phase 2 Trial with Guselkumab

Helliwell, P, Deodhar, A, Gottlieb, AB et al. (7 more authors) (2019) Comparing Composite Measures of Disease Activity in Psoriatic Arthritis: Results From a Randomized Phase 2 Trial with Guselkumab. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 1843.

Metadata

Authors/Creators:
  • Helliwell, P
  • Deodhar, A
  • Gottlieb, AB
  • Boehncke, W-H
  • Xu, XL
  • Xu, S
  • Wang, Y
  • Hsia, EC
  • Gladman, DD
  • Ritchlin, CT
Dates:
  • Published: 27 June 2019
  • Published (online): 27 May 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 26 Jul 2019 14:02
Last Modified: 26 Jul 2019 14:02
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/annrheumdis-2019-eular.643
Related URLs:

Share / Export

Statistics